Atlas Trials

A Mass Balance Study of [14C] MT1013 in Hemodialysis Subjects With Secondary Hyperparathyroidism

Clinical trial NCT07284043 · COMPLETED

Trial details

NCT number
NCT07284043
Sponsor
Shaanxi Micot Pharmaceutical Technology Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hemodialysis Subjects With Secondary Hyperparathyroidism
Start date
2025-11-27
Primary completion
2026-05-14
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.